Drug design at the atomic level to thwart COVID-19

The rapidly evolving SARS-CoV-2 virus threatens the progress made in curbing the COVID-19 pandemic. A promising novel drug candidate, designed at the atomic level, could help doctors halt the rise of lethal new drug resistant variants.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks